Unsuspected drug shortage is impacting the German HIV PrEP supply - results of a cross-sectional survey show: majority of PrEP users had to stop or switch to on-demand PrEP and higher unmet PrEP demand among women, diverse individuals, and those in rural or small-town areas
Daniel Schmidt, Göran Kirchner, Konstantinos Voulgaris, Martin Friebe, Viviane Bremer, Barbara Bartmeyer

TL;DR
A drug shortage in Germany is disrupting HIV PrEP access, with many users switching to on-demand use and higher unmet demand among women, diverse individuals, and those in rural areas.
Contribution
This survey reveals the real-world impact of PrEP shortages and highlights disparities in access and stress levels among affected populations.
Findings
63% of PrEP users paused or switched to on-demand use due to shortages.
Unmet PrEP demand was higher among women, diverse individuals, and those in rural or small-town areas.
High stress levels were reported by 78% of users, linked to reduced perceived HIV protection and higher sexual partner counts.
Abstract
To assess the implications of HIV pre-exposure prophylaxis (PrEP) shortages, we conducted a survey among PrEP users and individuals interested in PrEP. The survey explored coping strategies, HIV prevention and sexual behavior and stress levels due to the drug shortages. Furthermore, barriers to PrEP access among people with unmet PrEP demand were investigated. An anonymous online survey was conducted from 28.01.-27.02.2024. Recruitment occurred via social media, professional societies, network channels, and flyers at HIV specialists. Factors associated with high stress levels and unmet PrEP demand were investigated using multivariable logistic regression. Among 926 PrEP users, most were male (98%), aged 31–45 (54%), identified as men (97%), lived in large cities (54%), and used PrEP daily (78%). Due to the shortage, 63% paused or switched to on-demand use. Most intended to resume PrEP…
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Click any figure to enlarge with its caption.
Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7
Figure 8Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsHIV/AIDS Research and Interventions · HIV/AIDS Impact and Responses · HIV/AIDS drug development and treatment
